Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 162 of the 162 references it cites were found in a registry or an index.

Paracetamol use during pregnancy — a call for precautionary action

Open access

Abstract

Paracetamol ( N -acetyl- p -aminophenol (APAP), otherwise known as acetaminophen) is the active ingredient in more than 600 medications used to relieve mild to moderate pain and reduce fever. APAP is widely used by pregnant women as governmental agencies, including the FDA and EMA, have long considered APAP appropriate for use during pregnancy when used as directed. However, increasing experimental and epidemiological research suggests that prenatal exposure to APAP might alter fetal development, which could increase the risks of some neurodevelopmental, reproductive and urogenital disorders. Here we summarize this evidence and call for precautionary action through a focused research effort and by increasing awareness among health professionals and pregnant women. APAP is an important medication and alternatives for treatment of high fever and severe pain are limited. We recommend that pregnant women should be cautioned at the beginning of pregnancy to: forego APAP unless its use is medically indicated; consult with a physician or pharmacist if they are uncertain whether use is indicated and before using on a long-term basis; and minimize exposure by using the lowest effective dose for the shortest possible time. We suggest specific actions to implement these recommendations. This Consensus Statement reflects our concerns and is currently supported by 91 scientists, clinicians and public health professionals from across the globe.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41574-021-00553-7

Cites

162 of 162 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Associations between prenatal APAP exposure, reproductive and neurobehavioural development suggested from observational human studies. Human observational studies suggest prenatal N-acetyl-p-aminophenol (APAP) exposure might be associated with both reproductive and neurobehavioural abnormalities in both sexes. APAP exposure during pregnancy might increase risk of male urogenital and reproductive tract abnormalities, as studies have found an elevated risk of undescended testicles (cryptorchidism) and reduced distance between the anus and the base of the penis, a measure known as the anogenital distance (AGD). Both reduced AGD and cryptorchidism are indicators of disturbed masculinization and risk factors for reproductive disorders in later life. Prenatal APAP exposure has also been associated with earlier female pubertal development. Additionally, epidemiological studies consistently suggest prenatal APAP exposure might increase the risk of adverse neurodevelopmental and behavioural outcomes, such as attention deficit hyperactivity disorder (ADHD), autism spectrum disorder, language delay (in girls) and decreased intelligence quotient. Collectively, the studies suggest that the timing and duration of maternal APAP use are critical factors.
Fig. 1 Associations between prenatal APAP exposure, reproductive and neurobehavioural development suggested from observational human studies. Human observational studies suggest prenatal N-acetyl-p-aminophenol (APAP) exposure might be associated with both reproductive and neurobehavioural abnormalities in both sexes. APAP exposure during pregnancy might increase risk of male urogenital and reproductive tract abnormalities, as studies have found an elevated risk of undescended testicles (cryptorchidism) and reduced distance between the anus and the base of the penis, a measure known as the anogenital distance (AGD). Both reduced AGD and cryptorchidism are indicators of disturbed masculinization and risk factors for reproductive disorders in later life. Prenatal APAP exposure has also been associated with earlier female pubertal development. Additionally, epidemiological studies consistently suggest prenatal APAP exposure might increase the risk of adverse neurodevelopmental and behavioural outcomes, such as attention deficit hyperactivity disorder (ADHD), autism spectrum disorder, language delay (in girls) and decreased intelligence quotient. Collectively, the studies suggest that the timing and duration of maternal APAP use are critical factors.CC BY · PubMed Central
Fig. 2 Evidence of APAP disruption of reproductive and neurological development from animal studies. In vivo, in vitro and ex vivo studies have shown that N-acetyl-p-aminophenol (APAP) directly perturbs hormone-dependent processes, which leads to disrupted reproductive development and neurodevelopment in both sexes. Fetal exposure in rodents has been shown experimentally to cause reproductive disorders of the male urogenital tract, including abnormalities in testicular function, sperm abnormalities and sexual behaviour. Experiments have shown disruption of female ovarian development resulting in reduced oocyte number and subsequent early ovarian insufficiency and subsequent reduced fertility. Fetal APAP exposure has been demonstrated to induce changes in neurotransmission in the brain manifesting in altered cognitive function, behaviour and locomotion. The studies have shown that the effect of APAP is dependent on the timing of exposure in relation to specific developmental processes and duration as well as dose. AGD, anogenital distance.
Fig. 2 Evidence of APAP disruption of reproductive and neurological development from animal studies. In vivo, in vitro and ex vivo studies have shown that N-acetyl-p-aminophenol (APAP) directly perturbs hormone-dependent processes, which leads to disrupted reproductive development and neurodevelopment in both sexes. Fetal exposure in rodents has been shown experimentally to cause reproductive disorders of the male urogenital tract, including abnormalities in testicular function, sperm abnormalities and sexual behaviour. Experiments have shown disruption of female ovarian development resulting in reduced oocyte number and subsequent early ovarian insufficiency and subsequent reduced fertility. Fetal APAP exposure has been demonstrated to induce changes in neurotransmission in the brain manifesting in altered cognitive function, behaviour and locomotion. The studies have shown that the effect of APAP is dependent on the timing of exposure in relation to specific developmental processes and duration as well as dose. AGD, anogenital distance.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 162 references

Research works printed but not linked: 1

  1. Hay-Schmidt, A. et al. Prenatal exposure to paracetamol/acetaminophen and precursor aniline impairs masculinisation of male brain and behaviour. Reproduction 154, 145–152 (2017). · DOI

Cited by

See all 228

Metadata

Authors
Bauer, A. Z., Swan, S. H., Kriebel, D., Liew, Z., Taylor, H. S., Bornehag, C.-G., Andrade, A. M., Olsen, J., Jensen, R. H., Mitchell, R. T., Skakkebaek, N. E., Jégou, B., & Kristensen, D. M.
Affiliations
  • University of Massachusetts Lowell (US)
  • Icahn School of Medicine at Mount Sinai (US)
  • Yale University (US)
  • Yale New Haven Hospital (US)
  • Karlstad University (SE)
  • Aarhus University (DK)
  • University of Copenhagen (DK)
  • MRC Centre for Reproductive Health (GB)
  • Inserm (FR)
Corresponding author
Kristensen, David M.
Venue
Nature Reviews Endocrinology
Published
2021-09-23
Volume
17
Issue
12
Pages
757-766
ISSN
  • 1759-5029 (ISSN-L)
  • 1759-5037
OpenAlex
W3198986471
Cited by
228
References
162
Citations by year
2026: 47 · 2025: 53 · 2024: 38 · 2023: 43 · 2022: 39 · 2021: 8
FWCI
5.70
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Reviews Endocrinology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by)
  • Digitala vetenskapliga arkivet (Diva) (Karlstad University) (submittedVersion, other-oa)
  • Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by)
Funders
  • UK Research and Innovation (MR/S017151/1)
  • Lundbeckfonden (R324-2019-1881)
  • National Institutes of Health (UL1TR001863)
  • National Center for Advancing Translational Sciences
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
Keywords
paracetamol, pregnancy, prenatal drug exposure, fetal development, neurodevelopmental disorders, reproductive disorders, genitourinary diseases, precautionary action, drug use in pregnancy, dose minimization
MeSH terms
Acetaminophen, Female, Humans, Pregnancy, Fetal Development

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Paracetamol use during pregnancy — a call for precautionary action. https://app.cochat.ai/papers/10.1038/s41574-021-00553-7
The paper
Bauer, A. Z., Swan, S. H., Kriebel, D., Liew, Z., Taylor, H. S., Bornehag, C.-G., Andrade, A. M., Olsen, J., Jensen, R. H., Mitchell, R. T., Skakkebaek, N. E., Jégou, B., & Kristensen, D. M. (2021). Paracetamol use during pregnancy — a call for precautionary action. Nature Reviews Endocrinology. https://doi.org/10.1038/s41574-021-00553-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.